The diagnostic efficacy of FDG-PET in the local recurrence of hilar bile duct cancer

被引:13
作者
Chikamoto, Akira
Tsuji, Tatsuya
Takamori, Hiroshi
Kanemitsu, Keiichiro
Uozumi, Hideaki
Yamashita, Yasuyuki
Baba, Hideo
机构
[1] Kumamoto Univ, Dept Surg Gastroenterol, Fac Med & Pharmaceut Sci, Kumamoto 8608556, Japan
[2] Kumamoto Univ, Dept Diagnost Imaging, Fac Med & Pharmaceut Sci, Kumamoto 8608556, Japan
来源
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY | 2006年 / 13卷 / 05期
关键词
FDG-PET; hilar bile duct cancer; local recurrence;
D O I
10.1007/s00534-005-1086-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Purpose. It is frequently difficult to make an accurate diagnosis of the local recurrence of hilar bile duct cancer (HBC). We assessed the efficacy of fluorodeoxyglucose-positron emission tomography (FDG-PET) in diagnosing the local recurrence of HBC. Methods. Among 18 patients who had previously undergone resection of HBC, 5 were suspected of having a recurrence. These 5 patients were examined for recurrence by computed tomography (CT) and FDG-PET. A definitive diagnosis was determined either by pathological studies or by clinical follow-up. Results. Whereas CT showed a recurrent mass in only 1 patient, FDG-PET revealed the high uptake of FDG in all patients. Histopathological and/or cytological examinations confirmed the local recurrence of HBC in 4 patients. One false-positive result occurred in a patient with reflux cholangitis. One patient with a recurrent tumor was followed by FDG-PET after irradiation therapy. The high level of FDG uptake, which had been seen in that patient before irradiation, completely disappeared after treatment. Conclusions. When used in combination with other modalities. FDG-PET offered useful information for the diagnosis of a local recurrence of HBC. This highly sensitive imaging approach also appeared to be useful for follow-up examination after irradiation therapy.
引用
收藏
页码:403 / 408
页数:6
相关论文
共 13 条
[1]
Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma [J].
Anderson, CD ;
Rice, MH ;
Pinson, W ;
Chapman, WC ;
Chari, RS ;
Delbeke, D .
JOURNAL OF GASTROINTESTINAL SURGERY, 2004, 8 (01) :90-97
[2]
Brücher BLDM, 2001, ANN SURG, V233, P300
[3]
Neoplasms of the esophagus and stomach [J].
Dehdashti, F ;
Siegel, BA .
SEMINARS IN NUCLEAR MEDICINE, 2004, 34 (03) :198-208
[4]
PET and PET-CT for evaluation of colorectal carcinoma [J].
Delbeke, D ;
Martin, WH .
SEMINARS IN NUCLEAR MEDICINE, 2004, 34 (03) :209-223
[5]
FDG PET in the diagnosis of hilar cholangiocarcinoma [J].
Fritscher-Ravens, A ;
Bohuslavizki, KH ;
Broering, DC ;
Jenicke, L ;
Schäfer, H ;
Buchert, R ;
Rogiers, X ;
Clausen, M .
NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (12) :1277-1285
[6]
Actual long-term outcome of extrahepatic bile duct cancer after surgical resection [J].
Jang, JY ;
Kim, SW ;
Park, DJ ;
Ahn, YJ ;
Yoon, YS ;
Choi, MG ;
Suh, KS ;
Lee, KU ;
Park, YH .
ANNALS OF SURGERY, 2005, 241 (01) :77-84
[7]
Clinical role of 18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer [J].
Kato, T ;
Tsukamoto, E ;
Kuge, Y ;
Katoh, C ;
Nambu, T ;
Nobuta, A ;
Kondo, S ;
Asaka, M ;
Tamaki, N .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (08) :1047-1054
[8]
Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer [J].
Kim, S ;
Kim, SW ;
Bang, YJ ;
Heo, DS ;
Ha, SW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (02) :414-419
[10]
Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate [J].
Seyama, Y ;
Kubota, K ;
Sano, K ;
Noie, T ;
Takayama, T ;
Kosuge, T ;
Makuuchi, M .
ANNALS OF SURGERY, 2003, 238 (01) :73-83